Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Telefónica Deutschland extended growth path – fully on track for FY23 outlook: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png
EQS-News: Telefónica Deutschland extended growth path – fully on track for FY23 outlook
EQS-News: Telefónica Deutschland extended growth path – fully on track for FY23 outlook
eqs_en 
0 07.11.23
EQS-News: Evotec and Dewpoint Therapeutics enter strategic partnership in oncology: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec and Dewpoint Therapeutics enter strategic partnership in oncology
EQS-News: Evotec and Dewpoint Therapeutics enter strategic partnership in oncology
eqs_en 
0 07.11.23
EQS-News: MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
EQS-News: MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
eqs_en 
0 02.11.23
EQS-News: Evotec SE to announce results for the first nine months 2023 on 08 November 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec SE to announce results for the first nine months 2023 on 08 November 2023
EQS-News: Evotec SE to announce results for the first nine months 2023 on 08 November 2023
eqs_en 
0 01.11.23
EQS-News: Nemetschek Group: Q3 2023 shows strong, profitable growth –increased revenue guidance for financial year 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png
EQS-News: Nemetschek Group: Q3 2023 shows strong, profitable growth –increased revenue guidance for financial year 2023
EQS-News: Nemetschek Group: Q3 2023 shows strong, profitable growth –increased revenue guidance for financial year 2023
eqs_en 
0 26.10.23
EQS-News: Siltronic in Q3 2023 with an expected moderate development, annual outlook confirmed and specified : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-News: Siltronic in Q3 2023 with an expected moderate development, annual outlook confirmed and specified
EQS-News: Siltronic in Q3 2023 with an expected moderate development, annual outlook confirmed and specified
eqs_en 
0 26.10.23
EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
eqs_en 
0 25.10.23
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
eqs_en 
0 25.10.23
EQS-Adhoc: Nemetschek SE increases revenue guidance for the financial year 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png
EQS-Adhoc: Nemetschek SE increases revenue guidance for the financial year 2023
EQS-Adhoc: Nemetschek SE increases revenue guidance for the financial year 2023
eqs_en 
0 23.10.23
EQS-News: Nagarro SE: Nagarro's Supervisory Board confirms the Management Board for another three years: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro SE: Nagarro's Supervisory Board confirms the Management Board for another three years
EQS-News: Nagarro SE: Nagarro's Supervisory Board confirms the Management Board for another three years
eqs_en 
0 17.10.23
EQS-News: Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB': http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
EQS-News: Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
eqs_en 
0 05.10.23
EQS-News: Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy
EQS-News: Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy
eqs_en 
0 27.09.23
EQS-News: Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases
EQS-News: Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases
eqs_en 
0 26.09.23
EQS-News: 1&1 AG: 1&1 mobile network: launch of smartphone tariffs from December 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 AG: 1&1 mobile network: launch of smartphone tariffs from December 2023
EQS-News: 1&1 AG: 1&1 mobile network: launch of smartphone tariffs from December 2023
eqs_en 
0 18.09.23
EQS-News: MorphoSys Receives U.S. FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Receives U.S. FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer
EQS-News: MorphoSys Receives U.S. FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer
eqs_en 
0 12.09.23
EQS-News: Nagarro SE: Nagarro initiates change of group auditor: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro SE: Nagarro initiates change of group auditor
EQS-News: Nagarro SE: Nagarro initiates change of group auditor
eqs_en 
0 11.09.23
EQS-News: Nemetschek Group Forms New Executive Leadership Team for its Next Phase of Growth : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png
EQS-News: Nemetschek Group Forms New Executive Leadership Team for its Next Phase of Growth
EQS-News: Nemetschek Group Forms New Executive Leadership Team for its Next Phase of Growth
eqs_en 
0 05.09.23
EQS-News: Evotec SE reports results for the first half-year 2023 and provides corporate updates: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec SE reports results for the first half-year 2023 and provides corporate updates
EQS-News: Evotec SE reports results for the first half-year 2023 and provides corporate updates
eqs_en 
0 29.08.23
EQS-News: Evotec SE reports first half-year 2023 results on 29 August 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec SE reports first half-year 2023 results on 29 August 2023
EQS-News: Evotec SE reports first half-year 2023 results on 29 August 2023
eqs_en 
0 22.08.23
EQS-News: Nagarro posts 16.5% YoY revenue growth in constant currency in H1 2023 despite global macroeconomic challenges: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro posts 16.5% YoY revenue growth in constant currency in H1 2023 despite global macroeconomic challenges
EQS-News: Nagarro posts 16.5% YoY revenue growth in constant currency in H1 2023 despite global macroeconomic challenges
eqs_en 
0 14.08.23
EQS-Adhoc: Nagarro SE: Adjustment in guidance for FY 2023: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-Adhoc: Nagarro SE: Adjustment in guidance for FY 2023
EQS-Adhoc: Nagarro SE: Adjustment in guidance for FY 2023
eqs_en 
0 11.08.23
EQS-News: Bechtle Confirms Forecast after Successful Q2: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
EQS-News: Bechtle Confirms Forecast after Successful Q2
EQS-News: Bechtle Confirms Forecast after Successful Q2
eqs_en 
0 11.08.23
EQS-News: VARTA AG: VARTA AG looks to the future with growing confidence: https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Varta-Logo.svg/1000px-Varta-Logo.svg.png
EQS-News: VARTA AG: VARTA AG looks to the future with growing confidence
EQS-News: VARTA AG: VARTA AG looks to the future with growing confidence
eqs_en 
0 11.08.23
EQS-News: CANCOM SE: Significant revenue and gross profit growth in the first half-year: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM SE: Significant revenue and gross profit growth in the first half-year
EQS-News: CANCOM SE: Significant revenue and gross profit growth in the first half-year
eqs_en 
0 10.08.23
EQS-News: MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results
EQS-News: MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results
eqs_en 
0 09.08.23